{"id":341,"date":"2022-10-21T12:40:40","date_gmt":"2022-10-21T16:40:40","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/?p=341"},"modified":"2022-10-21T12:40:40","modified_gmt":"2022-10-21T16:40:40","slug":"doj-announces-an-enhanced-approach-to-corporate-criminal-enforcement","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2022\/10\/21\/doj-announces-an-enhanced-approach-to-corporate-criminal-enforcement\/","title":{"rendered":"DOJ Announces an Enhanced Approach to Corporate Criminal Enforcement"},"content":{"rendered":"<p>On September 15, 2022, Deputy Attorney General Lisa O. Monaco of the Department of Justice (DOJ) delivered a speech at New York University addressing new guidance on corporate criminal enforcement. Her speech made it clear that DOJ is prioritizing investigations and prosecutions against corporate entities. DOJ\u2019s approach in this area is fundamentally grounded in individual accountability and corporate responsibility. Building off those ideas, the new guidance provides for: (1) increased focus on individual liability; (2) consideration of the full criminal, civil and regulatory record of any company when deciding the appropriate resolution; (3) expanding voluntarily self-disclosure programs across DOJ; and (4) the consideration of compensation systems that reward or deter compliance when evaluating the strength of a company\u2019s compliance program. Monaco also announced increased transparency and consistency by DOJ when determining issues related to monitors. DOJ intends these policies to communicate to corporate entities that it is \u201cnot accepting business as usual\u201d and that personal liability and the specifics of a corporation\u2019s cooperation and integration of compliance programs will be heavily scrutinized in criminal corporate prosecutions.<\/p>\n<p>To read the full text of this Duane Morris\u00a0<em>Alert<\/em>, please\u00a0<a href=\"https:\/\/www.duanemorris.com\/alerts\/doj_announces_enhanced_approach_corporate_criminal_enforcement_1022.html\">visit the firm website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>On September 15, 2022, Deputy Attorney General Lisa O. Monaco of the Department of Justice (DOJ) delivered a speech at New York University addressing new guidance on corporate criminal enforcement. Her speech made it clear that DOJ is prioritizing investigations and prosecutions against corporate entities. DOJ\u2019s approach in this area is fundamentally grounded in individual &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/2022\/10\/21\/doj-announces-an-enhanced-approach-to-corporate-criminal-enforcement\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;DOJ Announces an Enhanced Approach to Corporate Criminal Enforcement&#8221;<\/span><\/a><\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[592,223,623,339,593,209,64,119],"ppma_author":[521],"class_list":["post-341","post","type-post","status-publish","format-standard","hentry","category-general","tag-brittany-pagnotta","tag-corporate","tag-criminal-enforcement","tag-department-of-justice","tag-eric-breslin","tag-frederick-ball","tag-guidance","tag-rick-ball"],"authors":[{"term_id":521,"user_id":6,"is_guest":0,"slug":"duanemorris3","display_name":"Duane Morris","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/843ff6e7a8fe5fc92109b47a45f34b6cf0ea499e6e788db23456c838b0ae6747?s=96&d=blank&r=g","author_category":"1","last_name":"Sullivan","first_name":"Margaret","job_title":"","user_url":"http:\/\/www.duanemorris.com","description":"<a href=\"http:\/\/www.duanemorris.com\">Visit the Duane Morris website.<\/a>"}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/341","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/comments?post=341"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/posts\/341\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/media?parent=341"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/categories?post=341"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/tags?post=341"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/lifescienceslaw\/wp-json\/wp\/v2\/ppma_author?post=341"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}